Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 4;12(12):CD010655.
doi: 10.1002/14651858.CD010655.pub3.

Interventions for leg cramps in pregnancy

Li Luo  1   2 , Kunyan Zhou  1   2   3 , Jing Zhang  1   2   3 , Liangzhi Xu  1   2   3 , Weiyao Yin  4
Affiliations

Interventions for leg cramps in pregnancy

Li Luo et al. Cochrane Database Syst Rev. .

Abstract

Background: Leg cramps are a common problem in pregnancy. Various interventions have been used to treat them, including drug, electrolyte and vitamin therapies, and non-drug therapies. This Cochrane Review is an update of a review first published in 2015.

Objectives: To assess the effectiveness and safety of different interventions for treating leg cramps in pregnancy.

Search methods: We searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (25 September 2019), and reference lists of retrieved studies.

Selection criteria: Randomised controlled trials (RCTs) of any intervention for the treatment of leg cramps in pregnancy compared with placebo, no treatment or other treatments. Quinine was excluded for its known adverse effects. Cluster-RCTS were eligible for inclusion. Quasi-RCTs and cross-over studies were excluded.

Data collection and analysis: Three review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. The certainty of the evidence was assessed using the GRADE approach.

Main results: We included eight small studies (576 women). Frequency of leg cramps was our primary outcome and secondary outcomes included intensity and duration of leg cramps, adverse outcomes for mother and baby and health-related quality of life. Overall, the studies were at low or unclear risk of bias. Outcomes were reported in different ways, precluding the use of meta-analysis and thus data were limited to single trials. Certainty of evidence was assessed as either low or very-low due to serious limitations in study design and imprecision. Oral magnesium versus placebo/no treatment The results for frequency of leg cramps were inconsistent. In one study, results indicated that women may be more likely to report never having any leg cramps after treatment (risk ratio (RR) 5.66, 95% confidence interval (CI) 1.35 to 23.68, 1 trial, 69 women, low-certainty evidence); whilst fewer women may report having twice-weekly leg cramps (RR 0.29, 95% CI 0.11 to 0.80, 1 trial, 69 women); and more women may report a 50% reduction in number of leg cramps after treatment (RR 1.42, 95% CI 1.09 to 1.86, 1 trial, 86 women, low-certainty evidence). However, other findings indicated that magnesium may make little to no difference in the frequency of leg cramps during differing periods of treatment. For pain intensity, again results were inconsistent. Findings indicated that magnesium may make little or no difference: mean total pain score (MD 1.80, 95% CI -3.10 to 6.70, 1 trial, 38 women, low-certainty evidence). In another study the evidence was very uncertain about the effects of magnesium on pain intensity as measured in terms of a 50% reduction in pain. Findings from another study indicated that magnesium may reduce pain intensity according to a visual analogue scale (MD -17.50, 95% CI -34.68 to -0.32,1 trial, 69 women, low-certainty evidence). For all other outcomes examined there may be little or no difference: duration of leg cramps (low to very-low certainty); composite outcome - symptoms of leg cramps (very-low certainty); and for any side effects, including nausea and diarrhoea (low certainty). Oral calcium versus placebo/no treatment The evidence is unclear about the effect of calcium supplements on frequency of leg cramps because the certainty was found to be very low: no leg cramps after treatment (RR 8.59, 95% CI 1.19 to 62.07, 1 study, 43 women, very low-certainty evidence). In another small study, the findings indicated that the mean frequency of leg cramps may be slightly lower with oral calcium (MD -0.53, 95% CI -0.72 to -0.34; 1 study, 60 women; low certainty). Oral vitamin B versus no treatment One small trial, did not report on frequency of leg cramps individually, but showed that oral vitamin B supplements may reduce the frequency and intensity (composite outcome) of leg cramps (RR 0.29, 95% CI 0.11 to 0.73; 1 study, 42 women). There were no data on side effects. Oral calcium versus oral vitamin C The evidence is very uncertain about the effect of calcium on frequency of leg cramps after treatment compared with vitamin C (RR 1.33, 95% CI 0.53 to 3.38, 1 study, 60 women, very low-certainty evidence). Oral vitamin D versus placebo One trial (84 women) found vitamin D may make little or no difference to frequency of leg cramps compared with placebo at three weeks (MD 2.06, 95% CI 0.58 to 3.54); or six weeks after treatment (MD 1.53, 95% CI 0.12 to 2.94). Oral calcium-vitamin D versus placebo One trial (84 women) found oral calcium-vitamin D may make little or no difference to frequency of leg cramps compared with placebo after treatment at three weeks (MD -0.30, 95% CI -1.55 to 0.95); and six weeks (MD 0.03, 95% CI -1.3 to 1.36). Oral calcium-vitamin D versus vitamin D One trial (84 women) found oral calcium-vitamin D may make little or no difference to frequency of leg cramps compared with vitamin D after treatment at three weeks (MD -1.35, 95% CI -2.84 to 0.14); and six weeks after treatment (MD -1.10, 95% CI -2.69 to 0.49).

Authors' conclusions: It is unclear from the evidence reviewed whether any of the interventions provide an effective treatment for leg cramps. This is primarily due to outcomes being measured and reported in different, incomparable ways so that data could not be pooled. The certainty of evidence was found to be low or very-low due to design limitations and trials being too small to address the question satisfactorily. Adverse outcomes were not reported, other than side effects for magnesium versus placebo/no treatment. It is therefore not possible to assess the safety of these interventions. The inconsistency in the measurement and reporting of outcomes meant that meta-analyses could not be carried out. The development of a core outcome set for measuring the frequency, intensity and duration of leg cramps would address these inconsistencies and mean these outcomes could be investigated effectively in the future.

Trial registration: ClinicalTrials.gov NCT01709968.

PubMed Disclaimer

Conflict of interest statement

Kunyan Zhou: none known.

Li Luo: none known.

Jing Zhang: none known.

Liangzhi Xu: none known.

Wenjuan Li: none known.

Figures

1
1
Study flow diagram.
2
2
'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1: Oral magnesium versus placebo/no treatment, Outcome 1: Frequency of leg cramps during treatment
1.2
1.2. Analysis
Comparison 1: Oral magnesium versus placebo/no treatment, Outcome 2: Frequency of leg cramps after treatment
1.3
1.3. Analysis
Comparison 1: Oral magnesium versus placebo/no treatment, Outcome 3: Frequency of leg cramps after treatment: never
1.4
1.4. Analysis
Comparison 1: Oral magnesium versus placebo/no treatment, Outcome 4: Frequency: 50% reduction in number of leg cramps
1.5
1.5. Analysis
Comparison 1: Oral magnesium versus placebo/no treatment, Outcome 5: Intensity of pain during treatment: mean total score
1.6
1.6. Analysis
Comparison 1: Oral magnesium versus placebo/no treatment, Outcome 6: Intensity of pain: 50% reduction in pain score
1.7
1.7. Analysis
Comparison 1: Oral magnesium versus placebo/no treatment, Outcome 7: Intensity of pain: visual analogue scale
1.8
1.8. Analysis
Comparison 1: Oral magnesium versus placebo/no treatment, Outcome 8: Duration: persisting symptoms after night‐time cramps
1.9
1.9. Analysis
Comparison 1: Oral magnesium versus placebo/no treatment, Outcome 9: Composite outcome: symptoms of leg cramps (intensity and frequency)
1.10
1.10. Analysis
Comparison 1: Oral magnesium versus placebo/no treatment, Outcome 10: Side effects
2.1
2.1. Analysis
Comparison 2: Oral calcium versus placebo/no treatment, Outcome 1: Frequency of leg cramps after treatment: never
2.2
2.2. Analysis
Comparison 2: Oral calcium versus placebo/no treatment, Outcome 2: Frequency of leg cramps after treatment
2.3
2.3. Analysis
Comparison 2: Oral calcium versus placebo/no treatment, Outcome 3: Composite outcome: symptoms of leg cramps (intensity and frequency)
2.4
2.4. Analysis
Comparison 2: Oral calcium versus placebo/no treatment, Outcome 4: Severity of leg cramps after treatment
3.1
3.1. Analysis
Comparison 3: Oral vitamin B versus no treatment, Outcome 1: Composite outcome: symptoms of leg cramps (intensity and frequency)
4.1
4.1. Analysis
Comparison 4: Oral calcium versus oral vitamin C, Outcome 1: Frequency of leg cramps after treatment: never
5.1
5.1. Analysis
Comparison 5: Oral vitamin D versus placebo, Outcome 1: Frequency of leg cramps
5.2
5.2. Analysis
Comparison 5: Oral vitamin D versus placebo, Outcome 2: Severity of leg cramps pain
5.3
5.3. Analysis
Comparison 5: Oral vitamin D versus placebo, Outcome 3: Duration of leg cramps
6.1
6.1. Analysis
Comparison 6: Oral Calcium‐vitamin D versus placebo, Outcome 1: Frequency of leg cramps
6.2
6.2. Analysis
Comparison 6: Oral Calcium‐vitamin D versus placebo, Outcome 2: Severity of leg cramps pain
6.3
6.3. Analysis
Comparison 6: Oral Calcium‐vitamin D versus placebo, Outcome 3: Duration of leg cramps
7.1
7.1. Analysis
Comparison 7: Oral Calcium‐vitamin D versus vitamin D, Outcome 1: Frequency of leg cramps
7.2
7.2. Analysis
Comparison 7: Oral Calcium‐vitamin D versus vitamin D, Outcome 2: Severity of leg cramps pain
7.3
7.3. Analysis
Comparison 7: Oral Calcium‐vitamin D versus vitamin D, Outcome 3: Duration of leg cramps
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

References

References to studies included in this review

Dahle 1995 {published data only}
    1. Dahle LO, Berg G, Hammar M, Hurtig M, Larsson L. The effect of oral magnesium substitution on pregnancy-induced leg cramps. American Journal of Obstetrics and Gynecology 1995;173:175-80. - PubMed
Hammar 1981 {published data only}
    1. Hammar M, Larsson L, Tegler L. Calcium treatment of leg cramps in pregnancy. Acta Obstetricia et Gynecologica Scandinavica 1981;60:345-7. - PubMed
Hammar 1987 {published data only}
    1. Hammar M, Berg G, Solheim F, Larsson L. Calcium and magnesium status in pregnant women. A comparison between treatment with calcium and vitamin C in pregnant women with leg cramps. International Journal of Vitamin and Nutrition Research 1987;57:179-83. - PubMed
Khoranrodi 2011 {published data only}
    1. Khoranrodi R, IRCT201009274824N1. Comparative study of calcium efficacy and placebo on leg muscle cramps during pregnancy in patients referred to clinics supervised by Bushehr University of Medical Sciences. https://en.irct.ir/trial/5172 (first received 5 February 2011).
Mansouri 2017 {published data only}
    1. Mansouri A, Mirghafourvand M, Charandabi SM, Najafi M. The effect of vitamin d and calcium plus vitamin d on leg cramps in pregnant women: a randomized controlled trial. Journal of Research in Medical Sciences 2017;22(1):24. - PMC - PubMed
    1. Mirghafourvand M. The effect of vitamin D and calcium plus vitamin D for leg cramps in pregnant women: a randomised controlled trial. https://en.irct.ir/trial/10789 (first received 4 May 2013).
Nygaard 2008 {published data only}
    1. Bohmer T, NCT00525317. Does oral magnesium substitution relieve magnesium induced leg cramps ? https://clinicaltrials.gov/ct2/show/NCT00525317 (first received 5 September 2007).
    1. Nygaard IH, Valbo A, Pethick SV, Bohmer T. Does oral magnesium substitution relieve pregnancy-induced leg cramps? European Journal of Obstetrics & Gynecology and Reproductive Biology 2008;141(1):23-6. - PubMed
Sohrabvand 2006 {published data only}
    1. Sohrabvand F, Shariat M, Haghollahi F. Vitamin B supplementation for leg cramps during pregnancy. International Journal of Gynecology & Obstetrics 2006;95(1):48-9. - PubMed
Supakatisant 2015 {published data only}ISRCTN03989660
    1. Phupong V. A randomized, double-blinded, placebo-controlled trial of oral magnesium for relief in pregnancy-induced leg cramps. Current Controlled Trials (http://www.controlled-trials.com/ISRCTN03989660) 2011 [accessed 31 January 2013].
    1. Supakatisant C, Phupong V. Oral magnesium for relief in pregnancy-induced leg cramps: a randomised controlled trial. Maternal & Child Nutrition 2015;11(2):139-45. - PMC - PubMed

References to studies excluded from this review

Griffith 1998 {published data only}
    1. Griffith EC, Crowther CA, Hiller JE, Wilson KJ, ACT Study Group. Leg cramps in pregnancy: ineffectiveness of calcium supplementation. In: 2nd Annual Congress of the Perinatal Society of Australia & New Zealand; 1998 March 30-April 4; Alice Springs, Australia. 1998:99.
Kohama 2006 {published data only}
    1. Kohama T, Inoue M. Pycnogenol alleviates pain associated with pregnancy. Phytotherapy Research 2006;20(3):232-4. - PubMed
Mauss 1970 {published data only}
    1. Mauss HJ. Muscular cramp in the calf caused by pregnancy. Therapy in a blind study [Schwangerschaftsbedingte Wadenkrampfe. Therapie im Blindversuch.]. Medizinische Welt 1970;36:1570-1. - PubMed
Mukherjee 1997 {published data only}
    1. Mukherjee J, Jong A, Wu MY, Tsim YL. Leg cramps in pregnancy and calcium supplementation. Acta Obstetricia et Gynecologica Scandinavica 1997;76(167):89.
Odendaal 1974 {published data only}
    1. Odendaal HJ. Calcium for the treatment of leg cramps during pregnancy [Kalsium vir die Behandeling van Beenkrampe tydens Swangerskap]. South African Medical Journal 1974;48:780-1. - PubMed
Robinson 1947 {published data only}
    1. Robinson M. Cramps in pregnancy. Journal of Obstetrics and Gynaecology of the British Commonwealth 1947;54:826-9. - PubMed
Rougin 2012 {published data only}
    1. Rougin M. Magnesium oxide monohydrate for nocturnal leg cramps (MgNLC); a prospective, randomized, double blind, placebo controlled clinical trial. ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 31 January 2014] 2012.
Shahraki 2006 {published data only}
    1. Shahraki AD. Effects of vitamin E, calcium carbonate and milk of magnesium on muscular cramps in pregnant women. Journal of Medical Sciences 2006;6(6):979-83.
Thauvin 1992 {published data only}
    1. Thauvin E, Fusselier M, Arnaud J, Faure H, Favier M, Coudray C, et al. Effects of multivitamin mineral supplement on zinc and copper status during pregnancy. Biological Trace Element Research 1992;32:405-14. - PubMed

References to studies awaiting assessment

Mirghafourvand 2015 {published data only}
    1. Mirghafourvand M, Mohammad-Alizadeh-Charandabi S, Mansouri A, Najafi M, Khodabande F. The effect of vitamin D and calcium plus vitamin D on sleep quality in pregnant women with leg cramps: a controlled randomized clinical trial. Journal of Isfahan Medical School 2015;32(320):2444-53.

Additional references

ADRAC 2002
    1. Adverse Drug Reactions Advisory Committee. Quinine and profound thrombocytopenia. Australian Adverse Drug Reactions Bulletin 2002;21(3):10.
Allen 2003
    1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Medicine 2003;4(2):101-19. - PubMed
Allen 2012
    1. Allen RE, Kirby KA. Nocturnal leg cramps. American Family Physician 2012;86(4):350-5. - PubMed
Baldinger 2012
    1. Baldinger R, Katzberg HD, Weber M. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No: CD004157. [DOI: 10.1002/14651858.CD004157.pub2] - DOI - PubMed
Blyton 2012
    1. Blyton F, Chuter V, Walter KE, Burns J. Non-drug therapies for lower limb muscle cramps. Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No: CD008496. [DOI: 10.1002/14651858.CD008496.pub2] - DOI - PMC - PubMed
Dayan 2002
    1. Dayan J, Creveuil C, Herlicoviez M, Herbel C, Baranger E, Savoye C, et al. Role of anxiety and depression in the onset of spontaneous preterm labor. American Journal of Epidemiology 2002;155:293-301. - PubMed
El‐Tawil 2015
    1. El‐Tawil S, Al Musa T, Valli H, Lunn MPT, Brassington R, El‐Tawil T, Weber M. Quinine for muscle cramps. Cochrane Database of Systematic Reviews 2015, Issue 4. Art. No: CD005044. [DOI: 10.1002/14651858.CD005044.pub3] - DOI - PubMed
FDA 2006
    1. Food, Drug Administration. Quinine: important warning. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108799... [accessed 20 July 2008] 2006 11 Dec.
Frusso 1999
    1. Frusso R, Zárate M, Augustovski F, Rubinstein A. Magnesium for the treatment of nocturnal leg cramps: a crossover randomized trial. Journal of Family Practice 1999;48(11):868-71. - PubMed
Garrison 2020
    1. Garrison SR, Korownyk CS, Kolber MR, Allan GM, Musini VM, Sekhon RK, Dugré N. Magnesium for skeletal muscle cramps. Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No: CD009402. [DOI: 10.1002/14651858.CD009402.pub3] - DOI - PMC - PubMed
Goodman 2001
    1. Goodman L, Gilman A. The Pharmacological Basis of Therapeutics. 10th edition. New York: McGraw-Hill, 2001.
Harvey 1939
    1. Harvey A. The mechanism of action of quinine in myotonia and myasthenia. JAMA 1939;112:1562-3.
Hensley 2009
    1. Hensley JG. Leg cramps and restless legs syndrome during pregnancy. Journal of Midwifery and Women's Health 2009;54(3):211-8. - PubMed
Hertz 1992
    1. Hertz G, Fast A, Feinsilver SH, Feinsilver CL, Albertario H, Schulman, et al. Sleep in normal late pregnancy. Sleep 1992;15(3):246-51. - PubMed
Hickey 1995
    1. Hickey CA, Cliver SP, Goldenberg RL, McNeal SF, Hoffman HJ. Relationship of psychosocial status to low prenatal weight gain among nonobese black and white women delivering at term. Obstetrics and Gynecology 1995;86:177-83. - PubMed
Higgins 2011
    1. Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Kanaan 2001
    1. Kanaan N, Sawaya R. Nocturnal leg cramps. Clinically mysterious and painful--but manageable. Geriatrics 2001;56(6):39-42. - PubMed
Katzberg 2010
    1. Katzberg HD, Khan AH, So YT. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American Academy of neurology. Neurology 2010;74(8):691-6. - PubMed
Langford 2003
    1. Langford NJ, Good AM, Laing WJ, Bateman DN. Quinine intoxications reported to the Scottish Poisons Information Bureau 1997-2002: a continuing problem. British Journal of Clinical Pharmacology 2003;56(5):576-8. - PMC - PubMed
Leal de Araújo 2020
    1. Leal de Araújo CA, Lorena SB, Sousa Cavalcanti GC, Souza Leão GL, Tenόrio GP, B Alves JG. Oral magnesium supplementation for leg cramps in pregnancy-An observational controlled trial. POLoS One 2020 Jan 10;15(1):e0227497. - PMC - PubMed
Lee 2004
    1. Lee KA, Gay CL. Sleep in late pregnancy predicts length of labor and type of delivery. American Journal of Obstetrics and Gynecology 2004;191(6):2041-6. - PubMed
Man‐Son‐Hing 1998
    1. Man-Son-Hing M, Wells G, Lau A. Quinine for nocturnal leg cramps a meta-analysis including unpublished data. Journal of General Internal Medicine 1998;13(9):600-6. - PMC - PubMed
Marcus 2003
    1. Marcus SM, Flynn HA, Blow FC, Barry KL. Depressive symptoms among pregnant women screened in obstetrics settings. Journal of Women's Health 2003;12:373-80. - PubMed
McGee 1990
    1. McGee SR. Muscle cramps. Archives of Internal Medicine 1990;150:511-8. - PubMed
Medsafe 2007
    1. Medsafe Pharmacovigilance Team, New Zealand Medicines and Medical Devices Safety Authority. Quinine - not for leg cramps anymore. http://www.medsafe.govt.nz/profs/PUArticles/watchingbriefsNov07.htm Prescriber Update 2007;28(1):2-6.
Merlino 2012
    1. Merlino G, Gigli GL. Sleep-related movement disorders. Neurological Sciences 2012;33(3):491-513. - PubMed
Miller 2005
    1. Milller TM, Layzer RB. Muscle cramps. Muscle and Nerve 2005;32(4):431-42. - PubMed
Mindell 2000
    1. Mindell JA, Jacobson BJ. Sleep disturbances during pregnancy. Journal of Obstetric, Gynecologic, and Neonatal Nursing 2000;29(6):590-7. - PubMed
Minetto 2013
    1. Minetto MA, Holobar A, Botter A, Farina D. Origin and development of muscle cramps. Exercise and Sport Sciences Reviews 2013;41(1):3-10. - PubMed
Nishimura 1976
    1. Nishimura H, Tanimura T. Clinical Aspects of the Teratogenicity of Drugs. Excerpta Medica Amsterdam, 1976.
Page 1953
    1. Page EW, Page EP. Leg cramps in pregnancy; etiology and treatment. Obstetrics and Gynecology 1953;1:94-100. - PubMed
Parisi 2003
    1. Parisi L, Pierelli F, Amabile G, Valente G, Calandriello E, Fattapposta F, et al. Muscular cramps: proposals for a new classification. Acta Neurologica Scandinavica 2003;107:176-86. - PubMed
Pedersen 1985
    1. Pedersen KE, Madsen JL, Klitgaard NA. Effect of quinine on plasma digoxin concentration and renal digoxin clearance. Acta Medica Scandinavica 1985;218(2):229-32. - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rondo 2003
    1. Rondo PH, Ferreira RF, Nogueira F, Ribeiro MC, Lobert H, Artes R. Maternal psychological stress and distress as predictors of low birth weight, prematurity and intrauterine growth retardation. European Journal of Clinical Nutrition 2003;57:266-72. - PubMed
Serrao 2000
    1. Serrao M, Rossi P, Cardinali P, Valente G, Parisi L, Pierelli F. Gabapentin treatment for muscle cramps: an open-label trial. Clinical Neuropharmacology 2000;23(1):45-9. - PubMed
Shaker 2005
    1. Shaker HK, Mackler L, Huber TE. What is the diagnostic approach to a patient with leg cramps? Journal of Family Practice 2005;54:817-8. - PubMed
Soares 2006
    1. Soares CN, Murray BJ. Sleep disorders in women: clinical evidence and treatment strategies. Psychiatric Clinics of North America 2006;29(4):1095-113. - PubMed
Sohrabvand 2009
    1. Sohrabvand F, Karimi M. Frequency and predisposing factors of leg cramps in pregnancy: a prospective clinical trial. Tehran University Medical Journal 2009;67(9):661-4.
Wacker 1968
    1. Wacker WE, Parisi AF. Magnesium metabolism. New England Journal of Medicine 1968;278(13):712-7. - PubMed
Young 2009
    1. Young G. Leg cramps. Clinical Evidence 2009;03:1113. - PMC - PubMed

References to other published versions of this review

Young 2002
    1. Young G, Jewell D. Interventions for leg cramps in pregnancy. Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No: CD000121. [DOI: 10.1002/14651858.CD000121] - DOI - PubMed
Zhou 2013
    1. Zhou K, Xu L, Li W, Zhang J. Interventions for leg cramps in pregnancy. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No: CD010655. [DOI: 10.1002/14651858.CD010655] - DOI - PubMed
Zhou 2015
    1. Zhou K, West HM, Zhang J, Xu L, Li W. Interventions for leg cramps in pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 8. Art. No: CD010655. [DOI: 10.1002/14651858.CD010655.pub2] - DOI - PubMed

Publication types

Associated data